Global Messenger RNA Vaccines and Therapeutics Market Research Report 2024, Forecast to 2032
Report Overview
An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.
The global Messenger RNA Vaccines and Therapeutics market size was estimated at USD 9800 million in 2023 and is projected to reach USD 28514.88 million by 2032, exhibiting a CAGR of 12.60% during the forecast period.
North America Messenger RNA Vaccines and Therapeutics market size was estimated at USD 3134.96 million in 2023, at a CAGR of 10.80% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Messenger RNA Vaccines and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Messenger RNA Vaccines and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Messenger RNA Vaccines and Therapeutics market in any manner.
Global Messenger RNA Vaccines and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BioNTech
Moderna
CureVac
Pfizer
Glaxo Smith Kline's
Daiichi Sankyo Company
Intellia Therapeutics
Arcturus Therapeutics
Emmy Vaccine
CSPC
CanSino
Fosun Pharma
Market Segmentation (by Type)
Self-amplifying
Conventional Non-amplifying
Market Segmentation (by Application)
Cancer
Infectious Diseases
Autoimmune Diseases
Others
Geographic Segmentation
•
An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.
The global Messenger RNA Vaccines and Therapeutics market size was estimated at USD 9800 million in 2023 and is projected to reach USD 28514.88 million by 2032, exhibiting a CAGR of 12.60% during the forecast period.
North America Messenger RNA Vaccines and Therapeutics market size was estimated at USD 3134.96 million in 2023, at a CAGR of 10.80% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Messenger RNA Vaccines and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Messenger RNA Vaccines and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Messenger RNA Vaccines and Therapeutics market in any manner.
Global Messenger RNA Vaccines and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BioNTech
Moderna
CureVac
Pfizer
Glaxo Smith Kline's
Daiichi Sankyo Company
Intellia Therapeutics
Arcturus Therapeutics
Emmy Vaccine
CSPC
CanSino
Fosun Pharma
Market Segmentation (by Type)
Self-amplifying
Conventional Non-amplifying
Market Segmentation (by Application)
Cancer
Infectious Diseases
Autoimmune Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
•
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Messenger RNA Vaccines and Therapeutics
1.2 Key Market Segments
1.2.1 Messenger RNA Vaccines and Therapeutics Segment by Type
1.2.2 Messenger RNA Vaccines and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Messenger RNA Vaccines and Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Messenger RNA Vaccines and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Messenger RNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Messenger RNA Vaccines and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Messenger RNA Vaccines and Therapeutics Sales Sites, Area Served, Product Type
3.6 Messenger RNA Vaccines and Therapeutics Market Competitive Situation and Trends
3.6.1 Messenger RNA Vaccines and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Messenger RNA Vaccines and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MESSENGER RNA VACCINES AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Messenger RNA Vaccines and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MESSENGER RNA VACCINES AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Messenger RNA Vaccines and Therapeutics Price by Type (2019-2024)
7 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Messenger RNA Vaccines and Therapeutics Market Sales by Application (2019-2024)
7.3 Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Messenger RNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
8 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Messenger RNA Vaccines and Therapeutics Sales by Region
8.1.1 Global Messenger RNA Vaccines and Therapeutics Sales by Region
8.1.2 Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Messenger RNA Vaccines and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Messenger RNA Vaccines and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Messenger RNA Vaccines and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Messenger RNA Vaccines and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Messenger RNA Vaccines and Therapeutics by Region (2019-2024)
9.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Messenger RNA Vaccines and Therapeutics Production
9.4.1 North America Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Messenger RNA Vaccines and Therapeutics Production
9.5.1 Europe Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Messenger RNA Vaccines and Therapeutics Production (2019-2024)
9.6.1 Japan Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Messenger RNA Vaccines and Therapeutics Production (2019-2024)
9.7.1 China Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 BioNTech
10.1.1 BioNTech Messenger RNA Vaccines and Therapeutics Basic Information
10.1.2 BioNTech Messenger RNA Vaccines and Therapeutics Product Overview
10.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Product Market Performance
10.1.4 BioNTech Business Overview
10.1.5 BioNTech Messenger RNA Vaccines and Therapeutics SWOT Analysis
10.1.6 BioNTech Recent Developments
10.2 Moderna
10.2.1 Moderna Messenger RNA Vaccines and Therapeutics Basic Information
10.2.2 Moderna Messenger RNA Vaccines and Therapeutics Product Overview
10.2.3 Moderna Messenger RNA Vaccines and Therapeutics Product Market Performance
10.2.4 Moderna Business Overview
10.2.5 Moderna Messenger RNA Vaccines and Therapeutics SWOT Analysis
10.2.6 Moderna Recent Developments
10.3 CureVac
10.3.1 CureVac Messenger RNA Vaccines and Therapeutics Basic Information
10.3.2 CureVac Messenger RNA Vaccines and Therapeutics Product Overview
10.3.3 CureVac Messenger RNA Vaccines and Therapeutics Product Market Performance
10.3.4 CureVac Messenger RNA Vaccines and Therapeutics SWOT Analysis
10.3.5 CureVac Business Overview
10.3.6 CureVac Recent Developments
10.4 Pfizer
10.4.1 Pfizer Messenger RNA Vaccines and Therapeutics Basic Information
10.4.2 Pfizer Messenger RNA Vaccines and Therapeutics Product Overview
10.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Glaxo Smith Kline's
10.5.1 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Basic Information
10.5.2 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Overview
10.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Market Performance
10.5.4 Glaxo Smith Kline's Business Overview
10.5.5 Glaxo Smith Kline's Recent Developments
10.6 Daiichi Sankyo Company
10.6.1 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Basic Information
10.6.2 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Overview
10.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Market Performance
10.6.4 Daiichi Sankyo Company Business Overview
10.6.5 Daiichi Sankyo Company Recent Developments
10.7 Intellia Therapeutics
10.7.1 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
10.7.2 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
10.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Market Performance
10.7.4 Intellia Therapeutics Business Overview
10.7.5 Intellia Therapeutics Recent Developments
10.8 Arcturus Therapeutics
10.8.1 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
10.8.2 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
10.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Market Performance
10.8.4 Arcturus Therapeutics Business Overview
10.8.5 Arcturus Therapeutics Recent Developments
10.9 Emmy Vaccine
10.9.1 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Basic Information
10.9.2 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Overview
10.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Market Performance
10.9.4 Emmy Vaccine Business Overview
10.9.5 Emmy Vaccine Recent Developments
10.10 CSPC
10.10.1 CSPC Messenger RNA Vaccines and Therapeutics Basic Information
10.10.2 CSPC Messenger RNA Vaccines and Therapeutics Product Overview
10.10.3 CSPC Messenger RNA Vaccines and Therapeutics Product Market Performance
10.10.4 CSPC Business Overview
10.10.5 CSPC Recent Developments
10.11 CanSino
10.11.1 CanSino Messenger RNA Vaccines and Therapeutics Basic Information
10.11.2 CanSino Messenger RNA Vaccines and Therapeutics Product Overview
10.11.3 CanSino Messenger RNA Vaccines and Therapeutics Product Market Performance
10.11.4 CanSino Business Overview
10.11.5 CanSino Recent Developments
10.12 Fosun Pharma
10.12.1 Fosun Pharma Messenger RNA Vaccines and Therapeutics Basic Information
10.12.2 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Overview
10.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Market Performance
10.12.4 Fosun Pharma Business Overview
10.12.5 Fosun Pharma Recent Developments
11 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Messenger RNA Vaccines and Therapeutics Market Size Forecast
11.2 Global Messenger RNA Vaccines and Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region
11.2.4 South America Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Messenger RNA Vaccines and Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Messenger RNA Vaccines and Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Messenger RNA Vaccines and Therapeutics by Type (2025-2032)
12.1.2 Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Messenger RNA Vaccines and Therapeutics by Type (2025-2032)
12.2 Global Messenger RNA Vaccines and Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Messenger RNA Vaccines and Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Messenger RNA Vaccines and Therapeutics
1.2 Key Market Segments
1.2.1 Messenger RNA Vaccines and Therapeutics Segment by Type
1.2.2 Messenger RNA Vaccines and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Messenger RNA Vaccines and Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Messenger RNA Vaccines and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Messenger RNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Messenger RNA Vaccines and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Messenger RNA Vaccines and Therapeutics Sales Sites, Area Served, Product Type
3.6 Messenger RNA Vaccines and Therapeutics Market Competitive Situation and Trends
3.6.1 Messenger RNA Vaccines and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Messenger RNA Vaccines and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MESSENGER RNA VACCINES AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Messenger RNA Vaccines and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MESSENGER RNA VACCINES AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Messenger RNA Vaccines and Therapeutics Price by Type (2019-2024)
7 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Messenger RNA Vaccines and Therapeutics Market Sales by Application (2019-2024)
7.3 Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Messenger RNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
8 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Messenger RNA Vaccines and Therapeutics Sales by Region
8.1.1 Global Messenger RNA Vaccines and Therapeutics Sales by Region
8.1.2 Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Messenger RNA Vaccines and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Messenger RNA Vaccines and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Messenger RNA Vaccines and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Messenger RNA Vaccines and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Messenger RNA Vaccines and Therapeutics by Region (2019-2024)
9.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Messenger RNA Vaccines and Therapeutics Production
9.4.1 North America Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Messenger RNA Vaccines and Therapeutics Production
9.5.1 Europe Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Messenger RNA Vaccines and Therapeutics Production (2019-2024)
9.6.1 Japan Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Messenger RNA Vaccines and Therapeutics Production (2019-2024)
9.7.1 China Messenger RNA Vaccines and Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Messenger RNA Vaccines and Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 BioNTech
10.1.1 BioNTech Messenger RNA Vaccines and Therapeutics Basic Information
10.1.2 BioNTech Messenger RNA Vaccines and Therapeutics Product Overview
10.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Product Market Performance
10.1.4 BioNTech Business Overview
10.1.5 BioNTech Messenger RNA Vaccines and Therapeutics SWOT Analysis
10.1.6 BioNTech Recent Developments
10.2 Moderna
10.2.1 Moderna Messenger RNA Vaccines and Therapeutics Basic Information
10.2.2 Moderna Messenger RNA Vaccines and Therapeutics Product Overview
10.2.3 Moderna Messenger RNA Vaccines and Therapeutics Product Market Performance
10.2.4 Moderna Business Overview
10.2.5 Moderna Messenger RNA Vaccines and Therapeutics SWOT Analysis
10.2.6 Moderna Recent Developments
10.3 CureVac
10.3.1 CureVac Messenger RNA Vaccines and Therapeutics Basic Information
10.3.2 CureVac Messenger RNA Vaccines and Therapeutics Product Overview
10.3.3 CureVac Messenger RNA Vaccines and Therapeutics Product Market Performance
10.3.4 CureVac Messenger RNA Vaccines and Therapeutics SWOT Analysis
10.3.5 CureVac Business Overview
10.3.6 CureVac Recent Developments
10.4 Pfizer
10.4.1 Pfizer Messenger RNA Vaccines and Therapeutics Basic Information
10.4.2 Pfizer Messenger RNA Vaccines and Therapeutics Product Overview
10.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Glaxo Smith Kline's
10.5.1 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Basic Information
10.5.2 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Overview
10.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Market Performance
10.5.4 Glaxo Smith Kline's Business Overview
10.5.5 Glaxo Smith Kline's Recent Developments
10.6 Daiichi Sankyo Company
10.6.1 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Basic Information
10.6.2 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Overview
10.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Market Performance
10.6.4 Daiichi Sankyo Company Business Overview
10.6.5 Daiichi Sankyo Company Recent Developments
10.7 Intellia Therapeutics
10.7.1 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
10.7.2 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
10.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Market Performance
10.7.4 Intellia Therapeutics Business Overview
10.7.5 Intellia Therapeutics Recent Developments
10.8 Arcturus Therapeutics
10.8.1 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
10.8.2 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
10.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Market Performance
10.8.4 Arcturus Therapeutics Business Overview
10.8.5 Arcturus Therapeutics Recent Developments
10.9 Emmy Vaccine
10.9.1 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Basic Information
10.9.2 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Overview
10.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Market Performance
10.9.4 Emmy Vaccine Business Overview
10.9.5 Emmy Vaccine Recent Developments
10.10 CSPC
10.10.1 CSPC Messenger RNA Vaccines and Therapeutics Basic Information
10.10.2 CSPC Messenger RNA Vaccines and Therapeutics Product Overview
10.10.3 CSPC Messenger RNA Vaccines and Therapeutics Product Market Performance
10.10.4 CSPC Business Overview
10.10.5 CSPC Recent Developments
10.11 CanSino
10.11.1 CanSino Messenger RNA Vaccines and Therapeutics Basic Information
10.11.2 CanSino Messenger RNA Vaccines and Therapeutics Product Overview
10.11.3 CanSino Messenger RNA Vaccines and Therapeutics Product Market Performance
10.11.4 CanSino Business Overview
10.11.5 CanSino Recent Developments
10.12 Fosun Pharma
10.12.1 Fosun Pharma Messenger RNA Vaccines and Therapeutics Basic Information
10.12.2 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Overview
10.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Market Performance
10.12.4 Fosun Pharma Business Overview
10.12.5 Fosun Pharma Recent Developments
11 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Messenger RNA Vaccines and Therapeutics Market Size Forecast
11.2 Global Messenger RNA Vaccines and Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region
11.2.4 South America Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Messenger RNA Vaccines and Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Messenger RNA Vaccines and Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Messenger RNA Vaccines and Therapeutics by Type (2025-2032)
12.1.2 Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Messenger RNA Vaccines and Therapeutics by Type (2025-2032)
12.2 Global Messenger RNA Vaccines and Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Messenger RNA Vaccines and Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Messenger RNA Vaccines and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Messenger RNA Vaccines and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Messenger RNA Vaccines and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Messenger RNA Vaccines and Therapeutics as of 2022)
Table 10. Global Market Messenger RNA Vaccines and Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Messenger RNA Vaccines and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Messenger RNA Vaccines and Therapeutics Product Type
Table 13. Global Messenger RNA Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Messenger RNA Vaccines and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Messenger RNA Vaccines and Therapeutics Market Challenges
Table 22. Global Messenger RNA Vaccines and Therapeutics Sales by Type (K MT)
Table 23. Global Messenger RNA Vaccines and Therapeutics Market Size by Type (M USD)
Table 24. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Messenger RNA Vaccines and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Messenger RNA Vaccines and Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) by Application
Table 30. Global Messenger RNA Vaccines and Therapeutics Market Size by Application
Table 31. Global Messenger RNA Vaccines and Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Messenger RNA Vaccines and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Messenger RNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Table 35. Global Messenger RNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Messenger RNA Vaccines and Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Messenger RNA Vaccines and Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Messenger RNA Vaccines and Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Messenger RNA Vaccines and Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Messenger RNA Vaccines and Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Messenger RNA Vaccines and Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. BioNTech Messenger RNA Vaccines and Therapeutics Basic Information
Table 52. BioNTech Messenger RNA Vaccines and Therapeutics Product Overview
Table 53. BioNTech Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. BioNTech Business Overview
Table 55. BioNTech Messenger RNA Vaccines and Therapeutics SWOT Analysis
Table 56. BioNTech Recent Developments
Table 57. Moderna Messenger RNA Vaccines and Therapeutics Basic Information
Table 58. Moderna Messenger RNA Vaccines and Therapeutics Product Overview
Table 59. Moderna Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Moderna Business Overview
Table 61. Moderna Messenger RNA Vaccines and Therapeutics SWOT Analysis
Table 62. Moderna Recent Developments
Table 63. CureVac Messenger RNA Vaccines and Therapeutics Basic Information
Table 64. CureVac Messenger RNA Vaccines and Therapeutics Product Overview
Table 65. CureVac Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. CureVac Messenger RNA Vaccines and Therapeutics SWOT Analysis
Table 67. CureVac Business Overview
Table 68. CureVac Recent Developments
Table 69. Pfizer Messenger RNA Vaccines and Therapeutics Basic Information
Table 70. Pfizer Messenger RNA Vaccines and Therapeutics Product Overview
Table 71. Pfizer Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Basic Information
Table 75. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Overview
Table 76. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Glaxo Smith Kline's Business Overview
Table 78. Glaxo Smith Kline's Recent Developments
Table 79. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Basic Information
Table 80. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Overview
Table 81. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Daiichi Sankyo Company Business Overview
Table 83. Daiichi Sankyo Company Recent Developments
Table 84. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
Table 85. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
Table 86. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Intellia Therapeutics Business Overview
Table 88. Intellia Therapeutics Recent Developments
Table 89. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
Table 90. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
Table 91. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Arcturus Therapeutics Business Overview
Table 93. Arcturus Therapeutics Recent Developments
Table 94. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Basic Information
Table 95. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Overview
Table 96. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Emmy Vaccine Business Overview
Table 98. Emmy Vaccine Recent Developments
Table 99. CSPC Messenger RNA Vaccines and Therapeutics Basic Information
Table 100. CSPC Messenger RNA Vaccines and Therapeutics Product Overview
Table 101. CSPC Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. CSPC Business Overview
Table 103. CSPC Recent Developments
Table 104. CanSino Messenger RNA Vaccines and Therapeutics Basic Information
Table 105. CanSino Messenger RNA Vaccines and Therapeutics Product Overview
Table 106. CanSino Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. CanSino Business Overview
Table 108. CanSino Recent Developments
Table 109. Fosun Pharma Messenger RNA Vaccines and Therapeutics Basic Information
Table 110. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Overview
Table 111. Fosun Pharma Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Fosun Pharma Business Overview
Table 113. Fosun Pharma Recent Developments
Table 114. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 115. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Messenger RNA Vaccines and Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 117. North America Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Messenger RNA Vaccines and Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 119. Europe Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 121. Asia Pacific Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Messenger RNA Vaccines and Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 123. South America Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Messenger RNA Vaccines and Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 127. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Messenger RNA Vaccines and Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 129. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 130. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Messenger RNA Vaccines and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Messenger RNA Vaccines and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Messenger RNA Vaccines and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Messenger RNA Vaccines and Therapeutics as of 2022)
Table 10. Global Market Messenger RNA Vaccines and Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Messenger RNA Vaccines and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Messenger RNA Vaccines and Therapeutics Product Type
Table 13. Global Messenger RNA Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Messenger RNA Vaccines and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Messenger RNA Vaccines and Therapeutics Market Challenges
Table 22. Global Messenger RNA Vaccines and Therapeutics Sales by Type (K MT)
Table 23. Global Messenger RNA Vaccines and Therapeutics Market Size by Type (M USD)
Table 24. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Messenger RNA Vaccines and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Messenger RNA Vaccines and Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) by Application
Table 30. Global Messenger RNA Vaccines and Therapeutics Market Size by Application
Table 31. Global Messenger RNA Vaccines and Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Messenger RNA Vaccines and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Messenger RNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Table 35. Global Messenger RNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Messenger RNA Vaccines and Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Messenger RNA Vaccines and Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Messenger RNA Vaccines and Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Messenger RNA Vaccines and Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Messenger RNA Vaccines and Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Messenger RNA Vaccines and Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Messenger RNA Vaccines and Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. BioNTech Messenger RNA Vaccines and Therapeutics Basic Information
Table 52. BioNTech Messenger RNA Vaccines and Therapeutics Product Overview
Table 53. BioNTech Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. BioNTech Business Overview
Table 55. BioNTech Messenger RNA Vaccines and Therapeutics SWOT Analysis
Table 56. BioNTech Recent Developments
Table 57. Moderna Messenger RNA Vaccines and Therapeutics Basic Information
Table 58. Moderna Messenger RNA Vaccines and Therapeutics Product Overview
Table 59. Moderna Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Moderna Business Overview
Table 61. Moderna Messenger RNA Vaccines and Therapeutics SWOT Analysis
Table 62. Moderna Recent Developments
Table 63. CureVac Messenger RNA Vaccines and Therapeutics Basic Information
Table 64. CureVac Messenger RNA Vaccines and Therapeutics Product Overview
Table 65. CureVac Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. CureVac Messenger RNA Vaccines and Therapeutics SWOT Analysis
Table 67. CureVac Business Overview
Table 68. CureVac Recent Developments
Table 69. Pfizer Messenger RNA Vaccines and Therapeutics Basic Information
Table 70. Pfizer Messenger RNA Vaccines and Therapeutics Product Overview
Table 71. Pfizer Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Basic Information
Table 75. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Overview
Table 76. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Glaxo Smith Kline's Business Overview
Table 78. Glaxo Smith Kline's Recent Developments
Table 79. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Basic Information
Table 80. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Overview
Table 81. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Daiichi Sankyo Company Business Overview
Table 83. Daiichi Sankyo Company Recent Developments
Table 84. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
Table 85. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
Table 86. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Intellia Therapeutics Business Overview
Table 88. Intellia Therapeutics Recent Developments
Table 89. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Basic Information
Table 90. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Overview
Table 91. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Arcturus Therapeutics Business Overview
Table 93. Arcturus Therapeutics Recent Developments
Table 94. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Basic Information
Table 95. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Overview
Table 96. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Emmy Vaccine Business Overview
Table 98. Emmy Vaccine Recent Developments
Table 99. CSPC Messenger RNA Vaccines and Therapeutics Basic Information
Table 100. CSPC Messenger RNA Vaccines and Therapeutics Product Overview
Table 101. CSPC Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. CSPC Business Overview
Table 103. CSPC Recent Developments
Table 104. CanSino Messenger RNA Vaccines and Therapeutics Basic Information
Table 105. CanSino Messenger RNA Vaccines and Therapeutics Product Overview
Table 106. CanSino Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. CanSino Business Overview
Table 108. CanSino Recent Developments
Table 109. Fosun Pharma Messenger RNA Vaccines and Therapeutics Basic Information
Table 110. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Overview
Table 111. Fosun Pharma Messenger RNA Vaccines and Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Fosun Pharma Business Overview
Table 113. Fosun Pharma Recent Developments
Table 114. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 115. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Messenger RNA Vaccines and Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 117. North America Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Messenger RNA Vaccines and Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 119. Europe Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 121. Asia Pacific Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Messenger RNA Vaccines and Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 123. South America Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Messenger RNA Vaccines and Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Messenger RNA Vaccines and Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 127. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Messenger RNA Vaccines and Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 129. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 130. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Messenger RNA Vaccines and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Messenger RNA Vaccines and Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Messenger RNA Vaccines and Therapeutics Market Size by Country (M USD)
Figure 11. Messenger RNA Vaccines and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Messenger RNA Vaccines and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Messenger RNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Messenger RNA Vaccines and Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Messenger RNA Vaccines and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Messenger RNA Vaccines and Therapeutics Market Share by Type
Figure 18. Sales Market Share of Messenger RNA Vaccines and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Messenger RNA Vaccines and Therapeutics by Type in 2023
Figure 20. Market Size Share of Messenger RNA Vaccines and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Messenger RNA Vaccines and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Messenger RNA Vaccines and Therapeutics Market Share by Application
Figure 24. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Messenger RNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Messenger RNA Vaccines and Therapeutics Market Share by Application in 2023
Figure 28. Global Messenger RNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Messenger RNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Messenger RNA Vaccines and Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Messenger RNA Vaccines and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Messenger RNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 44. China Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Messenger RNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Messenger RNA Vaccines and Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Messenger RNA Vaccines and Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Messenger RNA Vaccines and Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Messenger RNA Vaccines and Therapeutics Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Messenger RNA Vaccines and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Messenger RNA Vaccines and Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Messenger RNA Vaccines and Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Messenger RNA Vaccines and Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Messenger RNA Vaccines and Therapeutics Market Size by Country (M USD)
Figure 11. Messenger RNA Vaccines and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Messenger RNA Vaccines and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Messenger RNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Messenger RNA Vaccines and Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Messenger RNA Vaccines and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Messenger RNA Vaccines and Therapeutics Market Share by Type
Figure 18. Sales Market Share of Messenger RNA Vaccines and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Messenger RNA Vaccines and Therapeutics by Type in 2023
Figure 20. Market Size Share of Messenger RNA Vaccines and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Messenger RNA Vaccines and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Messenger RNA Vaccines and Therapeutics Market Share by Application
Figure 24. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Messenger RNA Vaccines and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Messenger RNA Vaccines and Therapeutics Market Share by Application in 2023
Figure 28. Global Messenger RNA Vaccines and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Messenger RNA Vaccines and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Messenger RNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Messenger RNA Vaccines and Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Messenger RNA Vaccines and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Messenger RNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Messenger RNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 44. China Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Messenger RNA Vaccines and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Messenger RNA Vaccines and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Messenger RNA Vaccines and Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Messenger RNA Vaccines and Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Messenger RNA Vaccines and Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Messenger RNA Vaccines and Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Messenger RNA Vaccines and Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Messenger RNA Vaccines and Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Messenger RNA Vaccines and Therapeutics Market Share Forecast by Application (2025-2032)
